Glibenclamide nanosuspension inhaler: development,in vitroandin vivoassessment
- Resource Type
- Authors
- Rania S. Abdel-Rashid; Fathy I Abd Allah; Abdelsabour A A Hassan; Fahima M. Hashem
- Source
- Drug Development and Industrial Pharmacy. 46:762-774
- Subject
- Pharmacology
business.industry
Inhaler
Organic Chemistry
Pharmaceutical Science
02 engineering and technology
021001 nanoscience & nanotechnology
030226 pharmacology & pharmacy
In vitro
Glibenclamide
03 medical and health sciences
0302 clinical medicine
In vivo
Drug Discovery
medicine
0210 nano-technology
business
medicine.drug
- Language
- ISSN
- 1520-5762
0363-9045
Objective: The development of nanosuspension for targeted delivery of glibenclamide as hypoglycemic agent to the lung in an inhaler dosage form.Method: Glibenclamide nanosuspension formulations wer...